CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer
Dusp5 and Zfp219 serve as critical regulators of age-related T cell dysfunction, with the loss of either driving T cells into an effector-like state that improves tumor control through distinct mechanisms within the aged tumor microenvironment.